$KIMS

$KIMS KIMS has consistently demonstrated strong top-line growth. The company reported a 27% year-over-year revenue increase in recent quarters, outpacing the broader Indian healthcare industry average. Strong Return on Capital: Historically, KIMS has maintained a strong Return on Capital Employed (RoCE) of over 30%, coupled with healthy operating cash flow generation. High-Yield Core Markets: The company's established hospitals in Telangana and Andhra Pradesh exhibit impressive EBITDA margins exceeding 25-30%.